• id Indonesia
  • en English
Indonesia for Global Justice
No Result
View All Result
  • Home
  • Media
  • Priority Agenda
  • Publications
  • About us
  • Home
  • Media
  • Priority Agenda
  • Publications
  • About us
No Result
View All Result
Indonesia for Global Justice
No Result
View All Result

Indonesia CSOs Letter – Re, Drop TRIPS Plus Provision on I-EU CEPA

May 9, 2023
in Campaign
Home Campaign
948
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

Jakarta, May 9th 2023

Mr. Valdis Dombrovkis Executive Vice-President European Commission
Rue de la Loi / Wetstraat 200 1049 Brussels
Email: cab-dombrovskis-contact@ec.europa.eu

Dear Commissioner,

Re: Drop TRIPS-plus provisions from Indonesia-EU CEPA

We the undersigned civil society from Indonesia are writing in advance of the next round of Indonesia-European Union Comprehensive Economic Partnership Agreement (CEPA) to call on the European Commission to drop all its TRIPS-plus (i.e. beyond the requirements of the TRIPS Agreement) demands from the Indonesia-EU Comprehensive Economic Partnership Agreement (CEPA).

In 2021, more than 90 civil society organizations (CSO) from all over the world wrote to you (see the attached letter) raising concerns about EU’s proposals on intellectual property (IP)1 in CEPA that inter alia include: limiting of parallel importation to national or regional exhaustion of rights; patent term extension for medicines for delays in marketing approval, with further extension for paediatrics; data and market exclusivity requirements including for new uses of older medicines; extensive requirements on IP enforcement (such as application of border measures to all IP).

We reiterate these concerns and stress that by pursuing these and other TRIPS-plus proposals, the EU is undermining the use of policy space and flexibilities provided by the TRIPS Agreement and reaffirmed in the Doha Declaration on TRIPS and public health with detrimental effects on public health in Indonesia.

As highlighted in the attached letter, TRIPS-plus proposals are denounced by human rights experts for their impact on access to affordable treatment. The Commission should also heed calls of the European Parliament (EP) that has also repeatedly urged the Commission to reject IP proposals that adversely impact access to medicines in trade negotiations.

We thus strongly urge the Commission to withdraw all TRIPS-plus provisions including those mentioned in this letter and to ensure that the CEPA does not include any provisions that hinders access to affordable pharmaceutical products in Indonesia.

Signatories

Indonesia for Global Justice Indonesia
AIDS Coalition Farmasi dan Kesehatan Reformasi
The Prakarsa
Yayasan Anak Bangsa Merajut Merajut Harapan (Angsa Merah Foundation)
Yayasan KARISMA (Karitas Sani Madani)
Yayasan Hipertensi Paru Indonesia (YHPI)/ Pulmonary Hypertension Association Indonesia


  1.  https://circabc.europa.eu/ui/group/09242a36-a438-40fd-a7af-fe32e36cbd0e/library/c780d397-feb5-4263- 8760-d14384d87456/details
Previous Post

Indonesia CSOs Letter – Re, Drop any demand on UPOV and plant variety protection from Indonesia-EU CEPA

Next Post

Open Letter to EU Commission “Drop TRIPS Plus Provision on Indonesia-EU CEPA”

Leave a Reply

Your email address will not be published. Required fields are marked *

Indonesia for Global Justice

Rengas Besar No.35 C, RT.14/RW.2, Jati Padang, Ps. Minggu,
Jakarta Selatan - Daerah Khusus Ibukota Jakarta 12540
Telepon: (021) 7941655

© 2023  - Indonesia for Global Justice


Berlangganan Sekarang!

Ikuti berita terbaru dari Indonesia for global justice, berlangganan sekarang!

Terimakasih telah berlangganan di Indonesia for global justice


  • id Indonesia
  • en English
No Result
View All Result

Indonesia for Global Justice
Jl.Rengas Besar No.35 C, RT.14/RW.2, Jati Padang, Ps. Minggu Jakarta Selatan - 12540
Telepon: (021) 7941655